Reuters logo
BRIEF-Corbus Pharmaceuticals announces completion of phase 2 study of Resunab for Systemic Sclerosis
2016年10月13日 / 中午11点37分 / 1 年前

BRIEF-Corbus Pharmaceuticals announces completion of phase 2 study of Resunab for Systemic Sclerosis

Oct 13 (Reuters) - Corbus Pharmaceuticals Holdings Inc :

* Corbus Pharmaceuticals announces completion of phase 2 study of resunab for systemic sclerosis

* Corbus Pharmaceuticals Holdings Inc - topline data on track to be reported in Q4 2016 Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below